skip to Main Content
  • This page as PDF

Benchmark Survey Results

Summary

A June 2014 Avalere survey asserts that while 90% of pharmaceutical and biotech manufacturers are offering cost-sharing assistance to exchange patients, the type of support, generosity and program structure vary widely.

Panelists

Moderator
Matt Brow , President & General Manager - Pharmacy, Life Sciences & Advisory

Matt Brow serves as the president and general manager of Inovalon’s Pharmacy, Life Sciences and Advisory business.

Back To Top